Veterinary CBD Research: Cannabis for Cancer Declaration is lining up partners for controlled cannabinoid trials in dogs, citing a 2026 systematic review that found CBD showed antiproliferative and pro-apoptotic effects across several canine cancers. DEA Rescheduling Watch: The DEA’s full marijuana rescheduling hearing transcript is out, with hundreds of corrections ordered before publication—another sign the federal shift is moving fast, even as legal fights loom. Medical CBD Product Push: Exilby (VER-01), a cannabis-derived non-opioid pain treatment, is advancing through regulatory review in Europe and the U.S., with Germany/Austria approval already in place and U.S. Phase 3 enrollment underway. Youth Health Trends: Vermont’s latest youth survey reports improved mental health and lower vaping, alcohol, and marijuana use—useful context for CBD-focused wellness claims. Policy & Markets: Canada hit a new monthly legal cannabis sales record, surpassing California as the world’s largest legal market by retail revenue. Local Cannabis Tensions: San Bernardino residents brought cannabis concerns to City Hall as council weighed community voices around a proposed cannabis business. Regulatory/Compliance Crackdowns: New York agencies raided two Oneida Square stores over synthetic cannabis, kratom, and flavored vape products. Politics & Cannabis: Florida’s Hope Florida Medicaid-misuse grand jury fallout continues, with Democrats demanding resignations tied to a scheme that included opposition to a recreational marijuana ballot measure.